NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Rahul Thorat
Advanced Centre for Treatment, Research & Education in Cancer - Maharashtra / India
Others
AD Scientific Index ID: 2004261
Tata Memorial Hospital
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Rahul Thorat's MOST POPULAR ARTICLES
1-)
Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancerN Chaudhary, BS Choudhary, SG Shah, N Khapare, N Dwivedi, ...International Journal of Cancer 149 (7), 1495-1511, 2021862021
2-)
MMP7 is required to mediate cell invasion and tumor formation upon Plakophilin3 lossS Basu, R Thorat, SN DalalPLoS one 10 (4), e0123979, 2015852015
3-)
Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patientsC Dmello, S Sawant, H Alam, P Gangadaran, S Mogre, R Tiwari, ...PLoS One 12 (2), e0172559, 2017422017
4-)
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancerP Iyer, SV Shrikhande, M Ranjan, A Joshi, N Gardi, R Prasad, ...International journal of cancer 144 (8), 2008-2019, 2019472019
5-)
Drug-sensitiveFGFR3 mutations in lung adenocarcinomaP Chandrani, K Prabhash, R Prasad, V Sethunath, M Ranjan, P Iyer, ...Annals of oncology 28 (3), 597-603, 2017452017
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept